The phenotypic variability of amyotrophic lateral sclerosis (Q38259758)

1 September 2017

1 reference

title

The phenotypic variability of amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

1 September 2017

0 references

2

Wim Robberecht

1 reference

1 September 2017

Bart Swinnen

1

1 reference

PubMed ID

25311585

1 September 2017

language of work or name

English

0 references

publication date

14 October 2014

1 reference

1 September 2017

Nature Reviews Neurology

1 reference

1 September 2017

10

1 reference

1 September 2017

661-670

1 reference

1 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2014.184

1 September 2017

0 references

cites work

State of play in amyotrophic lateral sclerosis genetics

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The changing scene of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Prognosis of amyotrophic lateral sclerosis with respiratory onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The epidemiology of ALS: a conspiracy of genes, environment and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Clinical and genetic heterogeneity of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Modelling the effects of penetrance and family size on rates of sporadic and familial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Natural history of young-adult amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Long-term survival in amyotrophic lateral sclerosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Neuropathology of sporadic amyotrophic lateral sclerosis of long duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Extensive genetics of ALS: a population-based study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The G93C Mutation in Superoxide Dismutase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Anticipation and phenotypic heterogeneity in korean familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Progressive muscular atrophy and other lower motor neuron syndromes of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

White matter pathology in ALS and lower motor neuron ALS variants: a diffusion tensor imaging study using tract-based spatial statistics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Flail arm syndrome of Vulpian-Bernhart's form of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Natural history and clinical features of the flail arm and flail leg ALS variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Early or late appearance of "dropped head syndrome" in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Mills' syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The frontotemporal syndromes of ALS. Clinicopathological correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Cognitive impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

An observational study of cognitive impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

FTD and ALS: a tale of two diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The effects of executive and behavioral dysfunction on the course of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

ALS and Frontotemporal Dysfunction: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The ALS/PDC syndrome of Guam and the cycad hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

ALS-parkinsonism-dementia complex of Kii and other related diseases in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Sporadic Parkinson disease and amyotrophic lateral sclerosis complex (Brait-Fahn-Schwartz disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The combination of dopa-responsive parkinsonian syndrome and motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Association of chorea and motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Chorea-ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic, and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Huntington chorea presenting with motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Ataxin-2 repeat-length variation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Amyotrophic lateral sclerosis with an acute hypertensive crises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Autonomic impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/25311585

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Autonomic dysfunction in the early stage of ALS with bulbar involvement

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Phenotypic Heterogeneity in a SOD1 G93D Italian ALS Family: An Example of Human Model to Study a Complex Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Pseudopolyneuritic form of ALS revisited: clinical and pathological heterogeneity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

The natural history of primary lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Hemiplegic ALS: Mills syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Dopa-responsive parkinsonism secondary to right temporal lobe haemorrahage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

UNC13A is a modifier of survival in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.184

Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25311585

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2014.184

1 reference

PubMed ID

25311585

Dimensions Publication ID

1 September 2017

0 references

1 reference

PubMed ID

25311585